An electrocardiograph (ECG) is a non-invasive medical test that provides a graphical record of the voltage versus time by recording the electrical signals associated with cardiac activity for some time. It is used to determine a patient’s response to drug therapy, reveal changes in heart function, and diagnose and assist in the treatment of heart disease. Three different types of leads are included in the 12-lead system—precordial, unipolar, and bipolar. Each lead presents a different aspect of the heart’s electrical activity by producing ECG waveforms. Electrocardiographs record small voltages of about one millivolt between electrodes; these small variations directly correspond to the heart’s electrical activity.
COVID-19 Impact analysis
COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
There has been an increase in the demand for medical supplies to take care of infected population. Respiratory support devices such as atomizers, life-support machines, oxygen generators, and monitors are among the majorly used medical devices in primary clinical treatment. Moreover, COVID-19 has led to a huge surge in demand for medical supplies such as personal protective equipment including masks, gloves, and protective eyeglasses. There is an increase in the need for medical supplies, both from healthcare professionals and civil population for precautionary measures, owing to the rise in number of COVID-19 cases worldwide. Manufacturers of these products have a chance to capitalize this increased demand for medical supplies to ensure adequate and continuous supply of personal protective equipment in the market. Therefore, COVID 19 is expected to have a significant impact on the 12 channel electrocardiograph market.
Top Impacting Factors
- Increase in cases of cardiovascular diseases, surge in geriatric populations, rise in demand for advanced equipment, and favorable government regulations are the factors that drive the growth of the 12 Channel Electrocardiograph market
- In addition, increase in healthcare expenditure; availability of skilled professionals; partnerships & collaborations between key players to facilitate the launch of novel equipment in the market; rise in R&D activities; and technological advancements are factors, which boost the growth of the 12 Channel Electrocardiograph market.
- However, lack of knowledge for proper handling of the device as well as complications associated with it, high cost of advanced ECG, unfavorable reimbursement policies, and saturation of market may hinder the market growth.
- Contrarily, an increase in focus toward acquisitions, mergers, and product launches presents new pathways in the industry.
Market Trends
Product launch and acquisition is the key strategy adopted by players in the 12 channel electrocardiograph market.
In February 2018, Advanced Materials and Bioengineering Research (AMBER) collaborated with Johnson & Johnson to launch 3D bio print center of excellence
On April 2021, EDAN Instruments, Inc., one of the top ECG exporters in China, held its global launch event of the new generation 12-channel electrocardiograph SE-1202. It can be helpful to clinical practices. The high sampling frequency of SE-1202 can grab the signal and reflect it on the wave forms.
Key Benefits of the Report
- This study presents the analytical depiction of the 12 Channel Electrocardiograph industries along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the 12 Channel Electrocardiograph market share.
- The current market is quantitatively analyzed to highlight the 12 Channel Electrocardiograph market growth scenarios.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed 12 Channel Electrocardiograph market analysis based on competitive intensity and how the competition will take shape in coming years.
Questions answered in the 12 Channel Electrocardiograph Report
- Which are the leading players active in the 12 Channel Electrocardiograph market?
- What are the current trends that will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities of the market?
- What future projections would help in taking further strategic steps?
- What is "12 Channel Electrocardiograph "?
- What is "12 Channel Electrocardiograph" Market prediction in the future?
- Who are the leading global players in the "12 Channel Electrocardiograph" Market?
- What are the current trends and predicted trends?
- What are the key benefits of the "12 Channel Electrocardiograph" Market report?
12 Channel Electrocardiograph Market Report Highlights
| Aspects | Details |
 By Product Type |
|
 By End User |
|
 By Region |
|
 Key Market Players | Philips, GE Healthcare, NIHON KOHDEN, BioTelemetry, Mortara Instrument, Fukuda Denshi, Suzuken, Mindray Medical, Hill-Rom, Spacelabs Healthcare |
Loading Table Of Content...
